The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

May 15, 2023

Study Completion Date

September 15, 2023

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

18F FDG PET/CT

"18F-FDG PET/CT Imaging: Preparation: Participants will be instructed to fast for at least 6 hours before the procedure to ensure low insulin levels and high FDG uptake by cancer cells.~Radiopharmaceutical Administration: Each participant will receive an intravenous injection of 18F-FDG, dosed at approximately 5.2 MBq/kg (0.14 mCi/kg) of body weight.~Imaging Protocol: After the injection, participants will rest in a quiet and dimly lit room for approximately 60 minutes to allow for optimal distribution and uptake of 18F-FDG by the tissues. Subsequently, they will be positioned on the PET/CT scanner bed, and imaging will be performed from the vertex to the proximal thighs. The scan will include a low-dose CT for attenuation correction followed by PET imaging, with the acquisition time adjusted based on the specific protocol (typically 2-3 minutes per bed position)."

DIAGNOSTIC_TEST

68Ga DOTATATE PET/CT

"68Ga-DOTATATE PET/CT Imaging: Preparation: No specific fasting is required for 68Ga-DOTATATE PET/CT. However, participants may be advised to hydrate well before the procedure.~Radiopharmaceutical Administration: Participants will receive an intravenous injection of 68Ga-DOTATATE, dosed at approximately 2.2 MBq/kg (0.06 mCi/kg) of body weight.~Imaging Protocol: Similar to the 18F-FDG protocol, after receiving 68Ga-DOTATATE, participants will wait for about 60 minutes to allow for sufficient uptake of the tracer. They will then undergo PET/CT scanning in a supine position, covering the same body regions as the FDG scan. A low-dose CT scan will be conducted first for attenuation correction, followed by the PET scan, with acquisition parameters tailored to the optimal detection of somatostatin receptor expression."

Trial Locations (2)

45030

Manisa Celal Bayar University Faculty of Medicine, General Surgery Department, Manisa

Manisa Celal Bayar University Faculty of Medicine, Nuclear Medicine Department, Manisa

All Listed Sponsors
lead

Celal Bayar University

OTHER

NCT06359054 - The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging | Biotech Hunter | Biotech Hunter